Epi One

About:

Epi One aims to take early cancer diagnosis to the next level by leveraging a novel epigenetic biomarker platform.

Twitter/X: EpiOneInc

Description:

We are on a mission to build a revolutionary cancer diagnosis platform to solve the challenge of early cancer prognosis and detection, as well as prediction of post-diagnosis cancer drug response.

Total Funding Amount:

$3.1M

Headquarters Location:

Brooklyn, New York, United States

Founded Date:

2016-06-08

Contact Email:

investors(AT)epi-one.com

Founders:

Neng Yang, MD, PhD, Sophia F. Fang, MD, PhD

Number of Employees:

1-10

Last Funding Date:

2024-05-06

IPO Status:

Private

Industries: